Market Analysis and Price Projections for the Drug NDC: 62135-0786
Understanding the National Drug Code (NDC)
To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number assigned by the FDA to identify drug products. This code includes the labeler code, product code, and package code, each providing specific information about the drug[1][5].
Identifying the Drug
The NDC 62135-0786 corresponds to a specific drug product. However, without direct access to the FDA's NDC Directory or other databases, we cannot identify the exact drug name, strength, dosage form, and formulation directly from the NDC alone. Typically, this information would be found in the FDA's NDC Directory or through other pharmaceutical databases.
Market Trends in the Pharmaceutical Industry
The pharmaceutical industry is undergoing significant changes driven by various factors:
-
Digital Transformation and Innovation: The industry is optimistic about 2025, with a focus on digital transformation, genomics, and biomarkers. These advancements are expected to improve treatment efficacy and reduce side effects[3].
-
Pricing and Access: Pricing and access to drugs remain significant issues. C-suite executives expect these factors to impact their strategies significantly in 2025. The median price increase for brand name drugs was 13.4% in 2022, which could serve as a benchmark for future price adjustments[2][3].
-
Generic Drugs and Biosimilars: Competition from generic drugs and biosimilars is a top trend, with 37% of respondents viewing this as a key concern. The patent cliff, with over $300 billion in sales at risk through 2030, is also driving interest in mergers and acquisitions[3].
Price Dynamics in the Pharmaceutical Market
-
Global Price Comparisons: Prices in the U.S. are significantly higher than in other regions. In 2022, the average price per unit in the U.S. was 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world[4].
-
Price Increases: Between 2017 and 2022, the U.S. saw an average price increase of 14% for prescription drugs, while prices in other regions decreased. This trend suggests that prices in the U.S. are likely to continue rising, albeit at varying rates[4].
Price Projections for NDC 62135-0786
Given the broader market trends:
-
Historical Price Data: Without specific historical price data for the drug identified by NDC 62135-0786, we can only make general projections based on industry trends. However, if the drug is a brand name product, it is likely to follow the median price increase trend observed in the industry.
-
Future Price Adjustments: If the drug is nearing patent expiration or faces competition from generics or biosimilars, its price may stabilize or decrease. However, if it remains a unique or highly demanded product, prices could continue to rise in line with industry averages.
Impact of Regulatory and Market Factors
-
Regulatory Changes: Any changes in FDA regulations, such as revisions to the NDC format or new approval processes, could impact the pricing and availability of the drug[1].
-
Market Competition: The entry of generic or biosimilar versions of the drug could significantly reduce its price. For instance, if the drug loses patent protection, it would likely face intense competition, leading to lower prices[3].
Example of Price Trends
To illustrate, consider the price trend for another drug, Imatinib Mesylate (NDC 00378-2245). The price per unit for this drug has fluctuated over time, with a recent increase from $0.50016 in September 2024 to $0.66780 in December 2024. This example shows how prices can vary based on market conditions and other factors[2].
Key Takeaways
- Understanding NDC: The NDC is a critical identifier for drug products, providing detailed information about the labeler, product, and packaging.
- Market Trends: The pharmaceutical industry is driven by digital transformation, pricing and access issues, and competition from generics and biosimilars.
- Price Dynamics: Prices in the U.S. are significantly higher than in other regions and are likely to continue rising.
- Regulatory and Market Factors: Changes in regulations and market competition can significantly impact drug prices.
FAQs
Q: What does the National Drug Code (NDC) represent?
A: The NDC is a unique, three-segment number that identifies a drug product, including the labeler code, product code, and package code.
Q: How do global price trends affect U.S. drug prices?
A: U.S. drug prices are significantly higher than in other regions. Between 2017 and 2022, U.S. prices increased by 14%, while prices in other regions decreased.
Q: What impact do generic drugs and biosimilars have on brand name drug prices?
A: The entry of generic or biosimilar versions can significantly reduce the prices of brand name drugs due to increased competition.
Q: How do regulatory changes affect drug pricing?
A: Regulatory changes, such as revisions to the NDC format or new approval processes, can impact the pricing and availability of drugs.
Q: What role does digital transformation play in the pharmaceutical industry?
A: Digital transformation, including advances in genomics and biomarkers, is expected to improve treatment efficacy and reduce side effects, and also boost operational efficiencies and drive innovations.
Sources
- FDA's National Drug Code Directory - FDA
- Latest drug prices and trends for NDC 00378-2245 - DrugPatentWatch
- 2025 life sciences outlook - Deloitte Insights
- International Market Size and Prices - ASPE
- National Drug Code Database Background Information - FDA
